Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-793-7 | CAS number: 541-85-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Physical data as well as information from toxicological data indicate that 5-methylheptan-3-one is absorbed and metabolized in the body. Furthermore, there are no indications for accumulation and the substance or its metabolites are likely eliminated from the body.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
A toxicokinetic assessment based on the physical properties (see ECHA Guidance on Information Requirements and Chemical Safety Assessment, R7c, 28.11.2012) and toxicity data was performed. NOTE: this is mostly a generic assessment based on general statements in the guidance document that are derived from physical parameters.
ABSORPTION
Based on the low molecular weight (ca. 130 g/mol), the structure, and physical data (medium water solubility, moderate log Pow value) of the compound (5-methyl-heptan-3-one), absorption through aqueous pores or bulk passage with water through the epithelial barrier and absorption by passive diffusion may occur, and the substance may dissolve into gastrointestinal fluids. The structure of the constituent indicates that ionization is not an issue; hence, pH will have no effect on absorption. Oral toxicity data show systemic effects (neurotoxicity) [1]. This is a further indication that the substance is absorbed.
Even though the compound (5-methyl-heptan-3-one) has “low volatility” based on its vapour pressure (270 Pa at 20°C) and its boiling point (159°C), it can be available for inhalation as vapour (max. vapour concentration at 20°C 2600 ppm[2]. Due to its moderate log Pow value (between 0 and 4) and its medium water solubility, the substance may be taken up via the respiratory tract and absorption may occur directly across the respiratory tract epithelium by passive diffusion. Inhalative toxicity studies with detailed observations are not available.
Physical data, i.e. physical state (liquid) and low molecular weight indicate that the substance may also be absorbed via the skin. The water solubility of the substance (1.92g/L) falls between 100-10’000 mg/l, a range where dermal absorption is anticipated to be moderate to high. In addition, the log Pow of 2.15 favours dermal absorption (values between 2 and 3 are optimal). Since the substance is not a surfactant (surface tension above 10 mN/m), dermal uptake and penetration is not expected to be enhanced by surface active properties. Dermal toxicity studies are not available. The substance has been observed to be mildly skin irritating and may cause defatting and dermatitis after prolonged repeated exposure[2]. Damage to the skin surface may enhance penetration.
DISTRIBUTION
From the small size and medium water solubility of the molecule, wide diffusive distribution in the body is expected. From its log Pow value (>0), the molecule is likely to distribute into cells.
In a newly performed subchronic oral toxicity guideline study [3], neurotoxicity was not observed. A previous subchronic oral toxicity study performed on only few male animals per dose [1] indicated a distribution into the central nervous system (CNS).
ACCUMULATION
5-methyl-heptan-3-one has a log Pow value under 3. Therefore, it would be unlikely to accumulate with the repeated intermittent exposure patterns normally encountered in the workplace but may accumulate if exposures are continuous. Once exposure to the substance stops, it will be gradually eliminated at a rate dependent on the half-life of the substance.
METABOLISM
No experimental data are available on the metabolism of 5-methyl-heptan-3-one. Other ketones have been shown to have neurotoxic effects and this effect was linked to the formation of gamma-diketones as metabolites[2]. For 5-methyl-heptan-3-one it was hypothesized that the metabolite 3-methylheptane-2,5-dione is formed [2] which may have led to the effects observed in the study cited in the distribution section.
ELIMINATION
From physical data, elimination via urine and exhaled air are likely the most prevalent pathways of excretion. Based on indications from the read-across substance 2-hexanone, the substance may be exhaled as CO2 and its metabolites may be excreted via the urine.
INDICATIONS FROM READ-ACROSS SUBSTANCES
Several studies on absorption, metabolism and elimination are available for 2-hexanone [2]: The substance is readily absorbed via the oral, dermal and inhalative route. Observed distribution of the substance was widespread in the body. Neurotoxicity of 2-hexanone is known to be caused by the metabolite 2,5-hexandione. Elimination takes place mainly as CO2via exhalation and excretion in the form of its metabolites via the urine.
2-hexanone has physical properties that likely favour absorption in comparison to 5-methyl-heptan-3-one (higher water solubility, higher vapour pressure, lower boiling point). However, the general pattern may be similar.
REFERENCES
[1] C.B. Salocks et. Al., Subchronic neurotoxicity of 5-methyl-3-heptanone in rats: Correlation of behavorial symptoms and neuropathology.Toxicologist 10, 121, 1990.
[2] Douglas C., Topping et al., Ketones of six to thirteen carbons in Bingman, E., Cohrssen, B., Powell C. H. (eds.), 2001, Patty's Toxicology, 5th Edition, John Wiley & Sons, Inc., New York, NY, USA.
[3] Nováková, Jana., Ethylamylketon 90-day Oral Toxicity Study in Wistar Rats., MediTox s.r.o study report 18/15/C, 2016-09-16.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.